The APPRAISE APixaban for PRevention of Acute Ischemic Safety Events brand, founded in 2007 (United States), from 496 sister brands and 17477 competing brands. APPRAISE APixaban for PRevention of Acute Ischemic Safety Events is a brand of BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York. APPRAISE APixaban for PRevention of Acute Ischemic Safety Events belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(APPRAISE APixaban for PRevention of Acute Ischemic Safety Events)
over 5 years*
USD 51.16